Inventor · disambiguated record
Annika Kers
Also filed as: KERS ANNIKA
16 granted patents·18 pending applications·92 citations·filing 2003–2019
92Inventor score
Files withASTRAZENECA AB24NPS PHARMA INC3ACTURUM REAL ESTATE AB2ARORA JALAJ1ASTRAZENECA AB AND NPS PHARMAC1
Top patents by PatentIndex Score
34 records- 0193US7585881B2Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2005·Granted Sep 8, 2009·36 cites·2 claims
- 0290US8865911B2Compounds and their use as BACE inhibitorsASTRAZENECA AB·Filed 2013·Granted Oct 21, 2014·13 cites·18 claims
- 0388US8415483B2Compounds and their use as BACE inhibitorsCSJERNYIK GABOR·Filed 2011·Granted Apr 9, 2013·14 cites·8 claims
- 0484US9248129B2Compounds and their use as BACE inhibitorsASTRAZENECA AB·Filed 2014·Granted Feb 2, 2016·5 cites·16 claims
- 0582US9822075B2NMDA antagonist prodrugsASTRAZENECA AB·Filed 2014·Granted Nov 21, 2017·3 cites·12 claims
- 0682US7855213B2CompoundsASTRAZENECA AB·Filed 2007·Granted Dec 21, 2010·7 cites·16 claims
- 0782US7456200B2CompoundsASTRAZENECA AB·Filed 2005·Granted Nov 25, 2008·9 cites·11 claims
- 0877US9918985B2Compounds and their use as BACE inhibitorsASTRAZENECA AB·Filed 2017·Granted Mar 20, 2018·1 cites·4 claims
- 0972US7576077B2Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2005·Granted Aug 18, 2009·2 cites·16 claims
- 1071US7960395B25,7-disubstituted thiazolo[4,5-d]pyrimidines for the selective inhibition of chemokine receptorsASTRAZENECA AB·Filed 2007·Granted Jun 14, 2011·1 cites·20 claims
- 1169US10815199B2NMDA antagonist prodrugsASTRAZENECA AB·Filed 2019·Granted Oct 27, 2020·0 cites·15 claims
- 1269US8158785B25,7-disubstituted[1.3]thiazolo [4,5-D] pyrimidin-2(3H)-amine derivatives and their use in therapyJOHANSSON ROLF·Filed 2007·Granted Apr 17, 2012·1 cites·18 claims
- 1365US10231967B2Compounds and their use as BACE inhibitorsASTRAZENECA AB·Filed 2018·Granted Mar 19, 2019·0 cites·2 claims
- 1462US2007293545A1Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 1562US2008015204A1Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 1662US2008045571A1Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 1762US2008015234A1Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 1861US10207994B2NMDA antagonist prodrugsASTRAZENECA AB·Filed 2017·Granted Feb 19, 2019·0 cites·4 claims
- 1957US2007179188A1Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsNPS PHARMA INC·Filed 2005·Application pending·0 cites
- 2056US2016184303A1Compounds and their use as bace inhibitorsASTRAZENECA AB·Filed 2015·Application pending·0 cites
- 2156US2011021540A1Bis-(Sulfonylamino) Derivatives in Therapy 066ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 2256US2009281138A1Bis-(Sulfonylamino) Derivatives in Therapy 066ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 2348US2006063772A1New compoundsARORA JALAJ·Filed 2005·Application pending·0 cites
- 2448US2009131468A1Bis-(Sulfonylamino) Derivatives in Therapy 065ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 2547US2006025414A1Poly-heterocyclic compounds and their use as metabotropic glutamate receptor antagonistsNPS PHARMA INC·Filed 2005·Application pending·0 cites
- 2647US2004132726A1New compoundsASTRAZENECA AB AND NPS PHARMAC·Filed 2003·Application pending·0 cites
- 2747US2007185100A1Poly-heterocyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2005·Application pending·0 cites
- 2845US2004152699A1CompoundsASTRAZENECA AND NPS PHARMACEUT·Filed 2003·Application pending·0 cites
- 2943US2011105537A15,7-disubstituted thiazolo[4,5-d]pyrimidines for the selective inhibition of chemokine receptorsASTRAZENECA AB·Filed 2011·Application pending·0 cites
- 3042US2011059992A1New CompoundsASTRAZENECA AB·Filed 2010·Application pending·0 cites
- 3140US2007185095A1Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonistsNPS PHARMA INC·Filed 2005·Application pending·0 cites
- 3234US10227296B2Bis(sulfonamide) derivatives and their use as mPGES inhibitorsACTURUM REAL ESTATE AB·Filed 2015·Granted Mar 12, 2019·0 cites·25 claims
- 3331US2010292279A1Bis-(Sulfonylamino) Derivatives in TherapyASTRAZENECA AB·Filed 2010·Application pending·0 cites
- 3423US10081614B2Bis(sulfonamide) derivatives and their use as mPGES inhibitorsACTURUM REAL ESTATE AB·Filed 2015·Granted Sep 25, 2018·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Annika Kers files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →